Skip to main content
Vaishali Pharma Limited logo

Vaishali Pharma Limited — Investor Relations & Filings

Ticker · VAISHALI ISIN · INE972X01022 LEI · 335800LHHVE3JLLKP681 National Stock Exchange of India Wholesale and retail trade
Filings indexed 429 across all filing types
Latest filing 2018-11-06 Regulatory Filings
Country IN India
Listing National Stock Exchange of India VAISHALI

About Vaishali Pharma Limited

https://www.vaishalipharma.com/

Vaishali Pharma Limited specializes in the sourcing, marketing, and distribution of a comprehensive range of healthcare products. The company’s portfolio encompasses Active Pharmaceutical Ingredients (APIs), finished formulations in various dosage forms such as tablets and injectables, and surgical supplies. It also provides veterinary products, herbal supplements, and nutraceuticals. The business model focuses on integrated supply chain management, facilitating the movement of medical products from manufacturing units to global markets. By adhering to international quality standards and leveraging an extensive distribution network, the company serves diverse therapeutic requirements. Its operations emphasize reliability in procurement and the delivery of cost-effective healthcare solutions to a global clientele across multiple regions, including Africa, Asia, and Latin America.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Regulatory Filings
2018-11-06 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a media release announcing that Vaishali Pharma Limited has been awarded the "Prestigious Rising Brands of Asia 2018-19". It contains no financial data, no regulatory filing references, no financial results, no management discussion of financial performance, no voting results, no capital changes, no legal proceedings, and no other regulatory or financial report content. It is a public relations announcement about an award received by the company, not a financial or regulatory filing. Therefore, it does not fit into any of the specific financial or regulatory filing categories. The best fitting category is Regulatory Filings (RNS) as a general announcement that does not fit elsewhere.
2018-10-04 English
Shareholders meeting
Regulatory Filings
2018-09-29 English
AGM/Book Closure
Regulatory Filings Classification · 95% confidence The document text contains only placeholders for images and no substantive text or financial data. The true document length is only 179 characters, which is extremely short and contains no report content. There is no indication of any report, announcement, or filing type. Given the lack of content, this document cannot be classified as a report or announcement but falls under the fallback category for miscellaneous filings.
2018-09-07 English
Shareholders meeting
Regulatory Filings
2018-09-05 English
Press Release
Regulatory Filings
2018-07-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.